Targeting Side Effects Associated with Androgen Deprivation Therapy Using Melatonin: A Randomized Trial on Hot...

Area of Science:

• Oncology
• Pharmacology
• Men's Health

Background:

• Prostate cancer incidence is rising, particularly in younger men.
• Androgen deprivation therapy (ADT) is a common treatment for prostate cancer, but causes significant side effects.
• Treatment-related symptoms like hot flashes and sexual dysfunction negatively impact patient quality of life.

Purpose of the Study:

• To investigate melatonin as an adjunct therapy for managing ADT-related symptoms in prostate cancer patients.
• To assess melatonin's efficacy in alleviating hot flashes and sexual dysfunction.
• To evaluate the impact of melatonin on the overall quality of life for prostate cancer patients.

Main Methods:

• A randomized, double-blind, placebo-controlled trial was conducted with 41 prostate cancer patients.
• Participants received either melatonin (3 mg twice daily) or placebo for four weeks.
• Symptom assessment included the Hot Flash Diary, IIEF, and FACT-P questionnaires.

Main Results:

• Melatonin significantly improved overall quality of life, as indicated by FACT-P scores (P < 0.05).
• A significant reduction in the frequency of mild hot flashes was observed in the melatonin group by week four (P < 0.05).
• Erectile function showed modest improvement in both groups, but not statistically significant (P > 0.05). Melatonin was well-tolerated.

Conclusions:

• Melatonin shows promise in alleviating vasomotor symptoms and enhancing quality of life for prostate cancer patients on ADT.
• The effect of melatonin on sexual function requires further investigation.
• Larger, long-term studies are necessary to validate findings and guide clinical practice.